He N G, Awasthi S, Singhal S S, Trent M B, Boor P J
Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.
Toxicol Appl Pharmacol. 1998 Sep;152(1):83-9. doi: 10.1006/taap.1998.8511.
The glutathione transferases (GSTs) are a family of ubiquitous enzymes that catalyze the conjugation of reduced glutathione (GSH) with reactive electrophiles. Rat vascular tissue contains GST isoforms that represent a major cellular defense mechanism against atherogenic alpha,beta-unsaturated aldehydes (Misra et al., Toxicol. Appl. Pharmacol. 133, 27-33, 1995). In this study we examined the role of GSTs in providing protection to cultured neonatal vascular smooth muscle cells (VSMCs) from the alpha,beta-unsaturated carbonyl cardiovascular toxins, allylamine and its metabolite, acrolein. Confluent cultured cells were exposed to 2 to 10 microM allylamine (a cardiovascular toxin that is metabolized in vivo and in vitro by VSMCs to the reactive aldehyde, acrolein) or to acrolein (2-10 microM) for 48 h; dose-cytotoxicity curves were generated utilizing a tetrazolium-dependent cytotoxicity assay. Concommittant treatment with sulfasalazine, an established inhibitor of GST, was found to markedly increase allylamine- or acrolein-induced cytotoxicity, decreasing the LC50 by two- to threefold at 50 to 100 microM sulfasalazine. A clonogenic survival assay in VSMCs exposed to these compounds for 4 h confirmed lethal toxicity and enhanced toxicity following cotreatment with sulfasalazine. Isobologram analysis (which statistically defines the limits of additivity of two independent treatments) showed that the sulfasalazine effect on both allylamine and acrolein cytotoxicity was supraadditive, or synergistic. Sulfasalazine was not cytotoxic to VSMCs in the range of concentrations that augmented acrolein or allylamine cytoxicity; total GST activity was inhibited, however, in a dose-dependent manner in that range. GST purified by GSH-affinity chromatography from pelleted untreated cells gave specific activities and kinetic constants consistent with those previously reported for rat aorta total GSTs. The catalytic efficiency (Kcat/Vm) was found to be much greater for 4-hydroxy-2-nonenal than for 1-chloro-2,4-dinitrobenzene (0.058 vs 0.4 s-1 mM-1). Western blot of purified total GSTs using antibodies against rec-mGSTA4-4 revealed a single band at 25 kDa, confirming the presence of a GST isozyme immunologically similar to rat GST8-8, which is known to utilize alpha,beta-unsaturated carbonyls as preferred substrates. Our data indicate that GSTs are an important defense in the vascular media, protecting blood vessels against alpha,beta-unsaturated carbonyl cardiovascular toxins that are involved in initiating atherosclerotic lesions.
谷胱甘肽转移酶(GSTs)是一类广泛存在的酶家族,可催化还原型谷胱甘肽(GSH)与活性亲电试剂的结合反应。大鼠血管组织中含有GST同工型,它们是针对致动脉粥样硬化的α,β-不饱和醛的主要细胞防御机制(Misra等人,《毒理学与应用药理学》133卷,27 - 33页,1995年)。在本研究中,我们检测了GSTs在保护培养的新生血管平滑肌细胞(VSMCs)免受α,β-不饱和羰基心血管毒素烯丙胺及其代谢产物丙烯醛侵害方面的作用。将汇合的培养细胞暴露于2至10微摩尔的烯丙胺(一种心血管毒素,在体内和体外均可被VSMCs代谢为活性醛丙烯醛)或丙烯醛(2 - 10微摩尔)中48小时;利用基于四氮唑的细胞毒性测定法生成剂量 - 细胞毒性曲线。发现用已证实的GST抑制剂柳氮磺胺吡啶进行联合处理可显著增加烯丙胺或丙烯醛诱导的细胞毒性,在50至100微摩尔柳氮磺胺吡啶时,将半数致死浓度(LC50)降低两至三倍。对暴露于这些化合物4小时的VSMCs进行克隆形成存活测定,证实了联合使用柳氮磺胺吡啶后的致死毒性和增强的毒性。等效线图分析(从统计学上定义两种独立处理相加性的限度)表明,柳氮磺胺吡啶对烯丙胺和丙烯醛细胞毒性的影响是超相加的,即协同作用。在增强丙烯醛或烯丙胺细胞毒性的浓度范围内,柳氮磺胺吡啶对VSMCs无细胞毒性;然而,在该浓度范围内,总GST活性以剂量依赖方式受到抑制。通过谷胱甘肽亲和层析从未处理的沉淀细胞中纯化得到的GST,其比活性和动力学常数与先前报道的大鼠主动脉总GSTs一致。发现4 - 羟基 - 2 - 壬烯醛的催化效率(Kcat/Vm)比1 - 氯 - 2,4 - 二硝基苯高得多(分别为0.058和0.4 s-1 mM-1)。使用抗重组小鼠GSTA4 - 4抗体对纯化的总GSTs进行蛋白质免疫印迹分析,在25 kDa处显示出一条单一带,证实存在一种与大鼠GST8 - 8免疫相似的GST同工酶,已知该同工酶优先利用α,β-不饱和羰基作为底物。我们的数据表明,GSTs是血管中层的重要防御机制,可保护血管免受参与引发动脉粥样硬化病变的α,β-不饱和羰基心血管毒素的侵害。